VTAK

Catheter Precision, Inc. (VTAK) | Rumor.io

Catheter Precision

VTAK

Attention (50-day avg)0%

Attention rank (50-day avg)#2,012

Bullish sentiment (50-day avg)87%

Price to earnings ratio0.03

Market capitalization541.4K

Earnings per share-4.07

Dividend yield (TTM)—

Revenue (annual)819K

Net income (annual)-17.7M

Social

What share of all stock conversation is about VTAK?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 17

Catheter Precision, Inc. (VTAK) expands LockeT commercialization across Latin America following successful August launch in Brazil, now in six hospitals.
VTAK has news, with a Globe Newswire release announcing expansion of LockeT commercialization across Latin America, but the stock price hasn't moved yet despite 11 million in volume.
VTAK is active on product launch, with a nano float of 3 million shares and high volume of 10 million, suggesting potential for significant price movement.

Generated by AI

Sentiment

Of the messages about VTAK that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% +44.44	58.33% -28.28	84.45% +6.92
Bearish	—	0% -44.44	41.67% +28.28	15.55% -6.92

Bullish· Aug 11

The company's stock price has increased by 11.6% to $0.343, indicating a strong bullish trend.
The low float and high short interest in $VTAK make it an attractive buying opportunity, with the potential for a significant price increase.
The stock's ability to break through resistance levels and close above previous highs, as seen in the 26c and 40-45c levels, suggests a strong upward momentum.

Bearish· Jul 16

$VTAK's high borrow rate makes it difficult to short, but its volume and price action suggest it will trade well below $0.60.
Despite a 720% increase in cost basis, $VTAK is still heavily shorted, and market makers are driving it down.
$VTAK has no support, with its price repeatedly rejected at $0.58, $0.59, and $0.60, and it will likely continue to sell off.

Generated by AI

Topics

Of the messages about VTAK that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	25.65%
Technical Analysis	—	—	0%	41.76%
Analysts	—	—	0%	16.23%
Macro	—	—	0%	16.23%
Controversies	—	—	0%	0.12%
Earnings	—	—	0%	0%

Announcements· Mar 11

Catheter Precision, Inc. (VTAK) secured up to $88 million in strategic institutional financing commitments to fund accelerated growth and fleet expansion.
The financing supports the company's next phase of growth, including fleet expansion and aircraft acquisitions, as well as market expansion across additional regional corridors.
The capital initiatives are expected to position the company as a more streamlined public company with significant exposure to the rapidly expanding regional aviation market.

Technical Analysis· Jul 8

VTAK has shown signs of momentum and a potential reversal, but may have been overbought after a large red candle.
A breakout above $1.40 could lead to a massive move towards $1.50, with the falling wedge chart pattern indicating a potential explosive move.
VTAK has been showing strong technical indicators, including a 15% gain, 1.7x relative volume, and a MACD turning green, suggesting a potential continuation of the upward trend.

Generated by AI

Community

Of the messages about VTAK, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	80%	38.3%	33.3%
Newcomers	—	20%	61.7%	66.7%

Regulars· Aug 27

The recent news of Catheter Precision achieving major commercial milestones with Cardinal Health, Johns Hopkins, and the placement of the first VIVO system in Germany has led to a spike in the stock price.
The regulars are speculating about the stock's potential to run up to $1.00 or more, with some expecting a 30% increase and others setting a target of $2.00.
There are concerns about the company's dilution of shares, with some calling for the company to file for a 180-day extension or to finish dilution, which could be a major hurdle for the stock's growth.

Newcomers· Aug 27

The newcomer is excited about Catheter Precision's first order from Cardinal Health, a healthcare giant with 50,000 employees and $200 billion in revenue, which could be a significant distribution channel for the company.
The newcomer is cautious about the stock's price, mentioning that it's hitting new all-time lows and expressing skepticism about the company's prospects, with one user joking that it's a "sucker's bet".
The newcomer is focused on the company's potential to gain traction in the medical products market, citing the importance of Cardinal Health's distribution channel and the potential for Catheter Precision to secure more orders from major healthcare institutions.

Generated by AI

LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL, S.C., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision Inc. (NYSE American: VTAK), Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a U.S.-based medical device company specializing in cardiac electrophysiology, today announced the expan

12d agoYahoo Finance

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE American: VTAK) m

1mo agoYahoo Finance Australia

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer Base Now Spans 174 Airports Across 19 States FORT MILL, S.C., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced that more than 10,000 consumer accounts are now registered on the Flyt

1mo agoYahoo Finance

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market

Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations FullPAC (NASDAQ Reserved Ticker: GOTV) to Introduce Flyte’s Cirrus Vision Jet Network to Qualified Congressional, Senate, Gubernatorial and Attorney General Campaigns Across the Eastern United States FORT MILL, S.C., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), doing

1mo agoYahoo Finance

Flyte to Provide Regional Aviation Services for FullPAC's Political Campaigns

Catheter Precision (VTAK), operating as Flyte, said late Tuesday it has entered into a strategic par

1mo agoYahoo Finance

Catheter Precision earnings beat by $17.54, revenue fell short of estimates

1mo agoInvesting.com

Also Discussed

Investors talking about VTAK also mention

#	Name	Attention
1	Innsuites Hospitality TrustIHT	0%new
2	PXDT - Pixie Dust Technologies, Inc.	——
3	Ernexa Therapeutics Inc.ERNA	0%0
4	Antelope Enterprise Holdings LimitedAEHL	0%new
5	ERYP - ERYTECH Pharma S.A.	——
6	China Online Education GroupCOE	0%new
7	Scopus Biopharma Inc.SCPS	0%new
8	China Liberal Education Holdings LimitedCLEU	0%new
9	Enveric Biosciences Inc.ENVB	0%0
10	TDH Holdings, Inc.PETZ	0%new

Catheter Precision, Inc.

Healthcare
Medical Devices

Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.

Website

Location

1670 Highway 160 West

Fort Mill, SC, 29708

United States

Social

What share of all stock conversation is about VTAK?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 17

Catheter Precision, Inc. (VTAK) expands LockeT commercialization across Latin America following successful August launch in Brazil, now in six hospitals.
VTAK has news, with a Globe Newswire release announcing expansion of LockeT commercialization across Latin America, but the stock price hasn't moved yet despite 11 million in volume.
VTAK is active on product launch, with a nano float of 3 million shares and high volume of 10 million, suggesting potential for significant price movement.

Generated by AI

Sentiment

Of the messages about VTAK that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% +44.44	58.33% -28.28	84.45% +6.92
Bearish	—	0% -44.44	41.67% +28.28	15.55% -6.92

Bullish· Aug 11

The company's stock price has increased by 11.6% to $0.343, indicating a strong bullish trend.
The low float and high short interest in $VTAK make it an attractive buying opportunity, with the potential for a significant price increase.
The stock's ability to break through resistance levels and close above previous highs, as seen in the 26c and 40-45c levels, suggests a strong upward momentum.

Bearish· Jul 16

$VTAK's high borrow rate makes it difficult to short, but its volume and price action suggest it will trade well below $0.60.
Despite a 720% increase in cost basis, $VTAK is still heavily shorted, and market makers are driving it down.
$VTAK has no support, with its price repeatedly rejected at $0.58, $0.59, and $0.60, and it will likely continue to sell off.

Generated by AI

Topics

Of the messages about VTAK that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	25.65%
Technical Analysis	—	—	0%	41.76%
Analysts	—	—	0%	16.23%
Macro	—	—	0%	16.23%
Controversies	—	—	0%	0.12%
Earnings	—	—	0%	0%

Announcements· Mar 11

Catheter Precision, Inc. (VTAK) secured up to $88 million in strategic institutional financing commitments to fund accelerated growth and fleet expansion.
The financing supports the company's next phase of growth, including fleet expansion and aircraft acquisitions, as well as market expansion across additional regional corridors.
The capital initiatives are expected to position the company as a more streamlined public company with significant exposure to the rapidly expanding regional aviation market.

Technical Analysis· Jul 8

VTAK has shown signs of momentum and a potential reversal, but may have been overbought after a large red candle.
A breakout above $1.40 could lead to a massive move towards $1.50, with the falling wedge chart pattern indicating a potential explosive move.
VTAK has been showing strong technical indicators, including a 15% gain, 1.7x relative volume, and a MACD turning green, suggesting a potential continuation of the upward trend.

Generated by AI

Community

Of the messages about VTAK, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	80%	38.3%	33.3%
Newcomers	—	20%	61.7%	66.7%

Regulars· Aug 27

The recent news of Catheter Precision achieving major commercial milestones with Cardinal Health, Johns Hopkins, and the placement of the first VIVO system in Germany has led to a spike in the stock price.
The regulars are speculating about the stock's potential to run up to $1.00 or more, with some expecting a 30% increase and others setting a target of $2.00.
There are concerns about the company's dilution of shares, with some calling for the company to file for a 180-day extension or to finish dilution, which could be a major hurdle for the stock's growth.

Newcomers· Aug 27

The newcomer is excited about Catheter Precision's first order from Cardinal Health, a healthcare giant with 50,000 employees and $200 billion in revenue, which could be a significant distribution channel for the company.
The newcomer is cautious about the stock's price, mentioning that it's hitting new all-time lows and expressing skepticism about the company's prospects, with one user joking that it's a "sucker's bet".
The newcomer is focused on the company's potential to gain traction in the medical products market, citing the importance of Cardinal Health's distribution channel and the potential for Catheter Precision to secure more orders from major healthcare institutions.

Generated by AI

Catheter Precision

Social

Sep 17

Bullish· Aug 11

Bearish· Jul 16

Announcements· Mar 11

Technical Analysis· Jul 8

Regulars· Aug 27

Newcomers· Aug 27

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market

Flyte to Provide Regional Aviation Services for FullPAC's Political Campaigns

Catheter Precision earnings beat by $17.54, revenue fell short of estimates

Also Discussed

Catheter Precision, Inc.

Company Information

Location

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market

Flyte to Provide Regional Aviation Services for FullPAC's Political Campaigns

Catheter Precision earnings beat by $17.54, revenue fell short of estimates

Also Discussed

Social

Sep 17

Bullish· Aug 11

Bearish· Jul 16

Announcements· Mar 11

Technical Analysis· Jul 8

Regulars· Aug 27

Newcomers· Aug 27